col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


8 Results       Page 1

 [1] 
MDPI AG: Scientia Pharmaceutica
  original article Date Title Authors   All Authors
1 [GO] 2023―Mar―07 Antiviral Molecular Targets of Essential Oils against SARS-CoV-2: A Systematic Review Muhammad Iqhrammullah, Diva Rayyan Rizki, Agnia Purnama, Teuku Fais Duta, Harapan Harapan, Rinaldi Idroes, Binawati Ginting
2 [GO] 2021―Feb―15 The Potential Role of Lithium as an Antiviral Agent against SARS-CoV-2 via Membrane Depolarization: Review and Hypothesis Abdallah Barjas Qaswal, Aiman Suleiman, Hasan Guzu, Taima’a Harb, Bashir Atiyat
3 [GO] 2021―Jan―11 Sedating Mechanically Ventilated COVID-19 Patients with Volatile Anesthetics: Insights on the Last-Minute Potential Weapons Aiman Suleiman, Abdallah Barjas Qaswal, Mazen Alnouti, Moh’d Yousef, Bayan Suleiman, Mohammad El Jarbeh, et al. (+4)
4 [GO] 2020―Dec―23 Uniting Electroceutical and Cosmeceutical Interventions in Combating Coronavirus Using Ԑ-Poly-l-Lysine Rania M. Hathout, Dina H. Kassem
5 [GO] 2020―Nov―23 The Potential Benefit of Beta-Blockers for the Management of COVID-19 Protocol Therapy-Induced QT Prolongation: A Literature Review Teuku Heriansyah, Indah Nur Chomsy, Lyra Febrianda, Tjut Farahiya Hadi, Titin Andri Wihastuti
6 [GO] 2020―Nov―19 Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein Alfredo Juárez-Saldívar, Edgar E. Lara-Ramírez, Francisco Reyes-Espinosa, Alma D. Paz-González, Juan Carlos Villalobos-Rocha, Gildardo Rivera
7 [GO] 2020―Aug―17 Antiviral Activity of Ivermectin Against SARS-CoV-2: An Old-Fashioned Dog with a New Trick-A Literature Review Mudatsir Mudatsir, Amanda Yufika, Firzan Nainu, Andri Frediansyah, Dewi Megawati, Agung Pranata, et al. (+4)
8 [GO] 2020―Jun―15 Remdesivir-Bringing Hope for COVID-19 Treatment Naser F. Al-Tannak, Ladislav Novotny, Adel Alhunayan
 [1] 

8 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec